Search Results - "BRISTOL, Andrew" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection

Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection

by Kaleko, Michael, Bristol, J. Andrew, Hubert, Steven, Parsley, Todd, Widmer, Giovanni, Tzipori, Saul, Subramanian, Poorani, Hasan, Nur, Koski, Perrti, Kokai-Kun, John, Sliman, Joseph, Jones, Annie, Connelly, Sheila
Published in Anaerobe (01.10.2016)

Get full text

Journal Article

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas

by Fantini, Massimo, David, Justin M, Saric, Olga, Dubeykovskiy, Alexander, Cui, Yongzhi, Mavroukakis, Sharon A, Bristol, Andrew, Annunziata, Christina M, Tsang, Kwong Y, Arlen, Philip M
Published in Frontiers in immunology (04.01.2018)

Get full text

Journal Article

Linked Tumor-Selective Virus Replication and Transgene Expression from E3-Containing Oncolytic Adenoviruses

Linked Tumor-Selective Virus Replication and Transgene Expression from E3-Containing Oncolytic Adenoviruses

by MINGZHU ZHU, BRISTOL, J. Andrew, YUEFENG XIE, MINA, Mervat, HONG JI, FORRY-SCHAUDIES, Suzanne, ENNIST, David L
Published in Journal of Virology (01.05.2005)

Get full text

Journal Article

Nonclinical Safety Assessment of SYN-004: An Oral β-lactamase for the Protection of the Gut Microbiome From Disruption by Biliary-Excreted, Intravenously Administered Antibiotics

Nonclinical Safety Assessment of SYN-004: An Oral β-lactamase for the Protection of the Gut Microbiome From Disruption by Biliary-Excreted, Intravenously Administered Antibiotics

by Kokai-Kun, John F, Bristol, J Andrew, Setser, John, Schlosser, Michael
Published in International journal of toxicology (01.05.2016)

Get more information

Journal Article

Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies

Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies

by Roberts, Tracey, Kokai-Kun, John F., Coughlin, Olivia, Lopez, Barbara Valero, Whalen, Heidi, Bristol, J. Andrew, Hubert, Steven, Longstreth, James, Lasseter, Kenneth, Sliman, Joseph
Published in Clinical drug investigation (01.09.2016)

Get full text

Journal Article

Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon

Formulation development of SYN-004 (ribaxamase) oral solid dosage form, a β-lactamase to prevent intravenous antibiotic-associated dysbiosis of the colon

by Bristol, Andrew, Hubert, Steven, Hofmann, Felix, Baer, Hans
Published in International journal of pharmaceutics (20.12.2017)

Get full text

Journal Article

Development of a Modified-Release Formulation of Lovastatin Targeted to Intestinal Methanogens Implicated in Irritable Bowel Syndrome With Constipation

Development of a Modified-Release Formulation of Lovastatin Targeted to Intestinal Methanogens Implicated in Irritable Bowel Syndrome With Constipation

by Hubert, Steven, Chadwick, Alan, Wacher, Vince, Coughlin, Olivia, Kokai-Kun, John, Bristol, Andrew
Published in Journal of pharmaceutical sciences (01.02.2018)

Get full text

Journal Article

Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL

Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL

by Burroughs, Kevin D, Kayda, Dawn B, Sakhuja, Kiran, Hudson, Yvette, Jakubczak, John, Bristol, J Andrew, Ennist, David, Hallenbeck, Paul, Kaleko, Michael, Connelly, Sheila
Published in Cancer gene therapy (01.02.2004)

Get full text

Journal Article

알칼리성 포스파타제 제형 및 이의 용도

알칼리성 포스파타제 제형 및 이의 용도

by FREIRE CRISTINA, KALEKO MICHAEL, STAPLETON RAY, BRISTOL ANDREW, HUBERT STEVEN
Year of Publication 08.02.2022

Get full text

Patent

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF

by Bristol, J.Andrew, Zhu, Mingzhu, Ji, Hong, Mina, Mervat, Xie, Yuefeng, Clarke, Lori, Forry-Schaudies, Suzanne, Ennist, David L
Published in Molecular therapy (01.06.2003)

Get full text

Journal Article

Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC

Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC

by Luka, Janos, Arlen, Philip M., Bristol, Andrew
Published in BioMed research international (01.01.2011)

Get full text

Journal Article

BETA-LACTAMASE FORMULATIONS AND USES THEREOF

BETA-LACTAMASE FORMULATIONS AND USES THEREOF

by KALEKO MICHAEL, CONNELLY SHEILA, BRISTOL ANDREW
Year of Publication 13.06.2017

Get full text

Patent

Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models

Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models

by Patel, Sandip Pravin, Bristol, Andrew, Saric, Olga, Wang, Xue-Ping, Dubeykovskiy, Alex, Arlen, Philip M., Morse, Michael A.
Published in Cancer Immunology, Immunotherapy (01.06.2013)

Get full text

Journal Article

Abstract C14: Tissue expression profile of novel tumor biomarkers identified by monoclonal antibodies

by Arlen, Philip M., Saric, Olga, Arlen, Myron, Bristol, Andrew
Published in Molecular cancer therapeutics (12.11.2011)

Get full text

Journal Article

Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC

Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC

by Luka, Janos, Bristol, Andrew, Arlen, Philip M.
Published in BioMed research international (2011)

Get full text

Journal Article

Biosynthesis of prothrombin : Intracellular localization of the vitamin K-dependent carboxylase and the sites of γ-carboxylation

Biosynthesis of prothrombin : Intracellular localization of the vitamin K-dependent carboxylase and the sites of γ-carboxylation

by ANDREW BRISTOL, J, RATCLIFFE, J. V, ROTH, D. A, JACOBS, M. A, FURIE, B. C, FURIE, B
Published in Blood (01.10.1996)

Get full text

Journal Article

270SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora

270SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora

by Kaleko, Michael, Bristol, Andrew, Connelly, Sheila, Koski, Pertti
Published in Open forum infectious diseases (01.12.2014)

Get full text

Journal Article

Abstract 4584: Pre-clinical studies of a novel antibody to treat pancreatic and colorectal cancers

Abstract 4584: Pre-clinical studies of a novel antibody to treat pancreatic and colorectal cancers

by Bristol, Andrew, Kantor, Judith, Luka, Janos, Stafford, Joe, Gupta, Rishab, Arlen, Philip
Published in Cancer research (Chicago, Ill.) (15.04.2011)

Get full text

Journal Article

Abstract 4582: Characterization of a new antibody that reacts with a tumor-specific variant of CEACAM-5 and CEACAM-6

Abstract 4582: Characterization of a new antibody that reacts with a tumor-specific variant of CEACAM-5 and CEACAM-6

by Du, Xiulian, Kantor, Judith, Luka, Janos, Stafford, Lewis J., Bristol, Andrew
Published in Cancer research (Chicago, Ill.) (15.04.2011)

Get full text

Journal Article

In Vivo Dose Threshold Effect of Adenovirus-Mediated Factor VIII Gene Therapy in Hemophiliac Mice

In Vivo Dose Threshold Effect of Adenovirus-Mediated Factor VIII Gene Therapy in Hemophiliac Mice

by Bristol, J. Andrew, Shirley, Pamela, Idamakanti, Neeraja, Kaleko, Michael, Connelly, Sheila
Published in Molecular therapy (01.09.2000)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
Next
[10]